AI in Drug Development – today and tomorrow
AI is re-shaping all stages of drug development from early drug discovery to clinical trials and post-market surveillance. This workshop will give a broad introduction to how agentic AI and non-agentic AI can support drug development efforts, highlight state-of-the-art initiatives and feature discussions about current challenges and new frontiers.
The workshop will feature speakers from both pharmaceutical industry and academia. It is organized by AI Lund, with support from COMPUTE, Medicon Village, Medicon Valley Alliance and SciLifeLab.
When: 7 December 2026 10.00 to 15.00 CET
Where: LUX Aula, Helgonavägen 3, Lund. Sweden
Registration: To participate is free of charge. Sign up at ai.lu.se no later than 4 December 12.00.
Keynote speaker: Magnus Fontes, Institut Roche
Moderator: Sonja Aits, Research team manager, Cell Death, Lysosomes and Artificial Intelligence
Event page: For latest information about the event, please visit https://www.ai.lu.se/2026-12-07
Confirmed speakers
- Magnus Fontes, Institut Roche. Magnus Fontes is General Manager of Institut Roche in Paris and adjunct professor of Mathematics at Lund University. He combines machine learning and mathematical modelling approaches to obtain new insights from clinical data and uncover biological mechanisms that can guide the development of new treatments.
- Irem Nasir, Bayer. Irem Nasir is a Lead Data Scientist at Bayer in Germany. She leads diverse AI initiatives, translating complex analytical work into real-world product impact and actively supports the AI transformation within her organization.
- Lars Juhl Jensen, ZS. Since 2025 Lars Juhl Jensen has worked as a Director at ZS in Copenhagen, leading the efforts to apply AI/ML techniques to molecular data. Prior to that he lead a successful research group at the University of Copenhagen, focusing on biomedical natural language processing and systems biology.
- Sonja Aits, Lund University. Sonja Aits leads a research group which develops deep learning methods and other data science approaches that help understand and integrate large scale biomedical and clinical data for drug development and health care. She also coordinates the "AI for Medicine and Life Science" focus area in AI Lund.
Additional speakers to be announced soon.
Programme outline
09.30 Registration, coffee and mingle
10.00 Presentations
12.00 Lunch and mingle
13.00 Presentations
15.00 Fika and mingle
Information
- When: to
- Where: LUX Aula, Helgonavägen 3, Lund. Sweden
- Organizer: Lund University
- Language: English
Registration
Please register no later than Friday 4 December 2026
Contact information
- Sonja Aits, AI Lund
- sonja.aits@med.lu.se
- https://www.ai.lu.se/